Literature DB >> 8515287

Mobilization of a vesamicol-insensitive pool of acetylcholine from a sympathetic ganglion by ouabain.

M A Prado1, M V Gomez, B Collier.   

Abstract

These experiments investigate the release of transmitter from the perfused superior cervical ganglia of cats induced by ouabain in the absence or presence of 2-(4-phenylpiperidino)cyclohexanol (vesamicol), a blocker of acetylcholine (ACh) uptake. Ouabain, perfused through the ganglia, released ACh in a Ca(2+)-dependent way. Vesamicol caused some inhibition of the release of ACh by ouabain; however, under this condition, the Na+,K(+)-ATPase inhibitor released five times more transmitter than did preganglionic stimulation at 5 Hz. Also, when ganglia exposed to vesamicol were depleted of the impulse-releasable pool of ACh, subsequent perfusion with ouabain released ACh, and this included ACh newly synthesized in the presence of vesamicol; this phenomenon could be inhibited by the lack of Ca2+ and presence of EGTA, and was completely abolished by perfusion with a medium containing 18 mM Mg2+. To test whether the release of this vesamicol-insensitive Ca(2+)-dependent pool by ouabain is associated with a decrease in the number of synaptic vesicles, ganglia treated with the ATPase inhibitor after the depletion of the impulse-releasable pool of ACh were fixed for electron microscopy. In the presence of Ca2+, coincident with the release of the vesamicol-insensitive pool of ACh, nerve terminals were almost depleted of synaptic vesicles; ganglia treated similarly, but with medium containing 18 mM Mg2+ instead of Ca2+, were not depleted of synaptic vesicles. These results suggest that ouabain releases a vesamicol-insensitive pool of ACh from the sympathetic ganglion and also support the notion that this compartment is vesicular and its exocytosis depends on extracellular Ca2+. It is suggested that empty-vesicle recycling in the presence of vesamicol restricts mobilization of full vesicles to release sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515287     DOI: 10.1111/j.1471-4159.1993.tb03536.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  The vesicular acetylcholine transporter is required for neuromuscular development and function.

Authors:  Braulio M de Castro; Xavier De Jaeger; Cristina Martins-Silva; Ricardo D F Lima; Ernani Amaral; Cristiane Menezes; Patricia Lima; Cintia M L Neves; Rita G Pires; Thomas W Gould; Ian Welch; Christopher Kushmerick; Cristina Guatimosim; Ivan Izquierdo; Martin Cammarota; R Jane Rylett; Marcus V Gomez; Marc G Caron; Ronald W Oppenheim; Marco A M Prado; Vania F Prado
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

2.  Acetylcholine release induced by the volatile anesthetic sevoflurane in rat brain cortical slices.

Authors:  Janice H Silva; Renato S Gomez; Ana Cristina N Pinheiro; Marcus V Gomez; Cristina Guatimosim
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

3.  Differences of the electrical and nicotinic receptor stimulation-evoked liberation of norepinephrine from chicken sympathetic neurons in culture: possible involvement of different pools of the transmitter.

Authors:  V Dolezal; A Schobert; G Hertting
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

4.  Halothane enhances exocytosis of [3H]-acetylcholine without increasing calcium influx in rat brain cortical slices.

Authors:  R S Gomez; M A Prado; F Carazza; M V Gomez
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction.

Authors:  Hermann A Rodrigues; Matheus de C Fonseca; Wallace L Camargo; Patrícia M A Lima; Patrícia M Martinelli; Lígia A Naves; Vânia F Prado; Marco A M Prado; Cristina Guatimosim
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.